Full Name
Dr. Anne Harduin-Lepers
Speaker Bio
Brief biographical statement:
Dr. Anne HARDUIN-LEPERS completed her PhD studies in Biochemistry at the University of Lille France in 1990. After postdoctoral training at the Johns Hopkins Hospital (Baltimore, USA), she started her independent research career at the Structural and Functional Glycobiology Unit (UGSF-UMR8576 CNRS, Lille, France) in 1993. She currently holds the position of CNRS Director of Research at UGSF. Her expertise spans areas such as Glycobiology, Molecular and Cell Biology, Biochemistry and Molecular Phylogeny. Her research interests are focused on Golgi-glycosyltransferases (GTs) acting in the last steps of glycoconjugates glycosylation. She uses integrated approaches to unravel the fundamental molecular and cellular mechanisms controlling terminal glycosylation. She studies sialylation in the light of GTs’ evolution thereby getting a better understanding of the biological importance of sialic acid pathway in Metazoa. She aims also to decipher implications of sialylated carbohydrates focusing on sialylated epitopes in human diseases such as inflammation, cancers and congenital disorders of glycosylation (CDG).
Dr. Anne HARDUIN-LEPERS completed her PhD studies in Biochemistry at the University of Lille France in 1990. After postdoctoral training at the Johns Hopkins Hospital (Baltimore, USA), she started her independent research career at the Structural and Functional Glycobiology Unit (UGSF-UMR8576 CNRS, Lille, France) in 1993. She currently holds the position of CNRS Director of Research at UGSF. Her expertise spans areas such as Glycobiology, Molecular and Cell Biology, Biochemistry and Molecular Phylogeny. Her research interests are focused on Golgi-glycosyltransferases (GTs) acting in the last steps of glycoconjugates glycosylation. She uses integrated approaches to unravel the fundamental molecular and cellular mechanisms controlling terminal glycosylation. She studies sialylation in the light of GTs’ evolution thereby getting a better understanding of the biological importance of sialic acid pathway in Metazoa. She aims also to decipher implications of sialylated carbohydrates focusing on sialylated epitopes in human diseases such as inflammation, cancers and congenital disorders of glycosylation (CDG).
Speaking At
